首页 | 本学科首页   官方微博 | 高级检索  
检索        


Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients
Authors:EK Alidjinou  L Bocket  V Pigot  V Lambert  C Hallaert  V Canva  D Hober
Institution:1. Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie EA3610, F-59000, Lille, France;2. CHU de Lille, Service des Maladies de l''appareil Digestif, Lille, France
Abstract:We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically infected patients. The overall agreement rate between assays was 94.2% and 98.8% for the detection of PC and BCP mutations, respectively.
Keywords:Hepatitis B virus  Precore  Basal core promoter  Mutations  Sanger sequencing  INNO-LiPA®
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号